These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Molecular Modeling Approach to Study the PPARγ-Ligand Interactions. Al Sharif M; Tsakovska I; Alov P; Vitcheva V; Diukendjieva A; Pajeva I Methods Mol Biol; 2019; 1966():261-289. PubMed ID: 31041755 [TBL] [Abstract][Full Text] [Related]
7. Benzoyl 2-methyl indoles as selective PPARgamma modulators. Acton JJ; Black RM; Jones AB; Moller DE; Colwell L; Doebber TW; Macnaul KL; Berger J; Wood HB Bioorg Med Chem Lett; 2005 Jan; 15(2):357-62. PubMed ID: 15603954 [TBL] [Abstract][Full Text] [Related]
8. The differential interactions of peroxisome proliferator-activated receptor gamma ligands with Tyr473 is a physical basis for their unique biological activities. Einstein M; Akiyama TE; Castriota GA; Wang CF; McKeever B; Mosley RT; Becker JW; Moller DE; Meinke PT; Wood HB; Berger JP Mol Pharmacol; 2008 Jan; 73(1):62-74. PubMed ID: 17940191 [TBL] [Abstract][Full Text] [Related]
9. 13-Oxo-ODE is an endogenous ligand for PPARgamma in human colonic epithelial cells. Altmann R; Hausmann M; Spöttl T; Gruber M; Bull AW; Menzel K; Vogl D; Herfarth H; Schölmerich J; Falk W; Rogler G Biochem Pharmacol; 2007 Aug; 74(4):612-22. PubMed ID: 17604003 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activities of novel aryl indole-2-carboxylic acid analogs as PPARgamma partial agonists. Dropinski JF; Akiyama T; Einstein M; Habulihaz B; Doebber T; Berger JP; Meinke PT; Shi GQ Bioorg Med Chem Lett; 2005 Nov; 15(22):5035-8. PubMed ID: 16153845 [TBL] [Abstract][Full Text] [Related]
11. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia. Berthiaume M; Laplante M; Tchernof A; Deshaies Y Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631 [TBL] [Abstract][Full Text] [Related]
12. An innovative method to study target protein-drug interactions by mass spectrometry. Müller MQ; de Koning LJ; Schmidt A; Ihling C; Syha Y; Rau O; Mechtler K; Schubert-Zsilavecz M; Sinz A J Med Chem; 2009 May; 52(9):2875-9. PubMed ID: 19379014 [TBL] [Abstract][Full Text] [Related]
13. Role of PPARgamma in renoprotection in Type 2 diabetes: molecular mechanisms and therapeutic potential. Yang J; Zhang D; Li J; Zhang X; Fan F; Guan Y Clin Sci (Lond); 2009 Jan; 116(1):17-26. PubMed ID: 19037881 [TBL] [Abstract][Full Text] [Related]
17. Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation. Kim KY; Ahn JH; Cheon HG Mol Pharmacol; 2007 Sep; 72(3):674-85. PubMed ID: 17535976 [TBL] [Abstract][Full Text] [Related]
18. Effects of natural ligands of PPARgamma on lipid metabolism in placental tissues from healthy and diabetic rats. Capobianco E; White V; Higa R; Martínez N; Jawerbaum A Mol Hum Reprod; 2008 Aug; 14(8):491-9. PubMed ID: 18621767 [TBL] [Abstract][Full Text] [Related]
19. The PPARgamma ligand rosiglitazone influences triacylglycerol metabolism in non-obese males, without increasing the transcriptional activity of PPARgamma in the subcutaneous adipose tissue. Joosen AM; Bakker AH; Kersten S; Westerterp KR Br J Nutr; 2008 Mar; 99(3):487-93. PubMed ID: 18177513 [TBL] [Abstract][Full Text] [Related]
20. The many faces of PPARgamma: anti-inflammatory by any means? Szanto A; Nagy L Immunobiology; 2008; 213(9-10):789-803. PubMed ID: 18926294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]